Tasly Pharmaceutical Group Co., Ltd
Clinical trials sponsored by Tasly Pharmaceutical Group Co., Ltd, explained in plain language.
-
New depression drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether a new medicine, JS1-1-01, is effective and safe for treating moderate to severe depression. It involved 267 adults who were randomly assigned to receive either the drug or a placebo (a dummy pill) for comparison. The main goal was to see if the drug redu…
Phase: PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New hope for controlling terrifying hallucinations in Parkinson's patients
Disease control CompletedThis study tested whether the drug pimavanserin is safe and effective at reducing psychosis symptoms like hallucinations and delusions in people with Parkinson's disease. It involved 248 patients who took either the drug or a placebo (inactive pill) for 43 days. The goal was to s…
Phase: PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Herbal remedy tested for rapid gout pain relief
Symptom relief CompletedThis study tested whether a traditional Chinese herbal medicine called Qingzhu Granules can safely reduce pain during sudden, painful gout attacks. It involved 472 adults experiencing a gout flare-up who took either the granules or a placebo (a look-alike with no medicine). Resea…
Phase: PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Symptom relief
Last updated Mar 16, 2026 15:24 UTC